About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,955 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,955 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1561-1580 of 18,955 trials

Active not recruitingPhase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic AtrophyThis Phase 3, multicenter, double-masked, parallel-group, placebo-controlled, randomized, fixed-dose clinical study is designed to evaluate the efficacy and safety of tinlarebant…NCT05949593·Phoenix, Arizona and 48 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedIncentives to Promote Medication Adherence Among HIV-Infected YouthMedication adherence is one of the most salient predictors of patient outcomes in the era following development of effective treatment for HIV infection.NCT02206906·Memphis, Tennessee

CompletedSDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)SUMMARY: This is an open label study combining Rituxan and SDX-105. Rituxan will be given on day 1 followed by a 30-60 minute intravenous infusion of SDX-105 on day 2 and day 3.NCT00076349·Anchorage, Alaska and 33 others

WithdrawnNatural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 StudyThe ultimate goal of this prospective natural history study is to define the natural history of the obstructive airway manifestations of Granulomatosis with polyangiitis (GPA).NCT03182049·Nashville, Tennessee

CompletedSmoking Cessation Invention in the Emergency Department (ED)The emergency department (ED) serves a vital and growing role in the US health care system, responsible for both the delivery of emergent medical care and for safety-net care for…NCT01173653·Nashville, Tennessee

RecruitingA Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)The goal of this clinical trial is to learn if a drug called TNX-102 SL works to treat moderate to severe major depressive disorder in adults.NCT07621237·Phoenix, Arizona and 26 others

Enrolling by invitationAlzheimer's Plasma ExtensionThe goal of this observational study is to learn how Alzheimer's disease-related blood biomarkers, brain amyloid, and memory and thinking abilities change over time.NCT06416072·Birmingham, Alabama and 55 others

RecruitingA Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive LifileucelA Phase 1/2, open-label study of a modified interleukin-2 fusion protein (IOV 3001) in participants with previously treated, unresectable or metastatic melanoma who will receive…NCT06940739·Denver, Colorado and 4 others

CompletedSafety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast CancerThis is a phase 1b/2 study of the safety and efficacy of sapanisertib (MLN0128) in combination with exemestane or fulvestrant therapy in women with estrogen receptor…NCT02049957·Los Angeles, California and 39 others

CompletedEfficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.The purpose of this study is to determine the efficacy and safety of alogliptin, once daily (QD), taken in combination with insulin for the treatment of Type 2 Diabetes.NCT00286429·Phoenix, Arizona and 59 others

TerminatedClinical Trial for Ovarian Cancer (OvaRex®)This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients.NCT00050375·Huntsville, Alabama and 61 others

TerminatedA Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell CarcinomaThe safety and tolerability of CVX-060 have been established in the first-in-human clinical trial, CVX-060-101.NCT00982657·Scottsdale, Arizona and 6 others

CompletedStudy of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung CancerThis is a randomized, open-label, multicenter, phase 2 study comparing Paclitaxel/Carboplatin with or without bavituximab in patients that have previously untreated locally…NCT01160601·Chandler, Arizona and 39 others

UnknownSTREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle GlaucomaA study of the Streamline Surgical System versus competitorNCT05280366·Fayetteville, Arkansas and 19 others

CompletedPrevention of Serious Adverse Events Following AngiographyThe purpose of this research study is to compare the effectiveness of intravenous isotonic sodium bicarbonate with intravenous isotonic sodium chloride and oral N-acetylcysteine…NCT01467466·Tucson, Arizona and 53 others

UnknownEvaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of BradykinesiaInvestigate the safety and tolerability of umbilical cord-derived allogeneic mesenchymal stem cells to treat patients with Bradykinesia.NCT04385056·Paducah, Kentucky and 2 others

Not yet recruitingHealth Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)This multi-site study will test whether an opportunistic AI-based CAC screening and notification intervention can improve cholesterol treatment and lower cholesterol levels in…NCT07355894·Los Angeles, California and 5 others

CompletedPembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)The purpose of this study was to evaluate the efficacy and safety of pembrolizumab plus epacadostat compared to sunitinib or pazopanib in participants with locally…NCT03260894·Scottsdale, Arizona and 139 others

CompletedA Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)The purpose of this study was to evaluate the efficacy and safety of pembrolizumab plus epacadostat with platinum-based chemotherapy versus pembrolizumab plus platinum-based…NCT03322566·Daphne, Alabama and 93 others

CompletedMedication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-studyThis is a sub-study of NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs; Unique protocol ID: 2019-0429-1).NCT03911466·Jacksonville, Florida and 11 others

PreviousPage 79 of 948Next

Diabetes

in Tennessee

Heart Diseasein Tennessee